Stewart Cole


Stewart studied microbiology in the UK at the University of Wales prior to earning his Doctor of Philosophy in molecular genetics from the University of Sheffield in 1979. Subsequently, he embarked on a career as a research scientist at the University of Umeå (Sweden) and the Max-Planck-Institut in Tübingen (Germany).  In 1983 he joined the Institut Pasteur (Paris, France), where he was the Head of the bacterial molecular genetics unit, a professor, and finally, the Institute’s Scientific Director.  In 2007, Professor Cole moved to the Ecole Polytechnique Fédérale de Lausanne (EPFL) where he leads a world-class research unit dedicated to TB drug discovery, and serves as the Director of the Global Health Institute.

Professor Cole has been the recipient of many national and international prizes and distinctions.  In 2009, he was awarded the World Health Organization’s STOP-TB Partnership Kochon Prize for “his visionary leadership and groundbreaking accomplishments in genetic research on M. tuberculosis and the quest to develop effective new TB drugs”.

For nearly four decades Professor Stewart Cole has enjoyed a rich and varied career working and teaching in universities and research institutes in several different European countries.  His research accomplishments in microbiology have been widely acclaimed and are of direct relevance to global health and disease-control in both the developing world and the industrialized nations.